Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.01−0.37 (-10.81%)
Close on Nov 17, 2026Market cap $58.22MP/E –Yield –
Corbus Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Corbus Pharmaceuticals's enterprise value was -$43.26M on Nov 11, 2026, against $40.67M a year earlier. Over the last 5 years it ranged from -$84.39M to $556.48M, with a median of -$318.77K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$43.26M | – |
| 2025 | Dec 31, 2025 | -$1.95M | – |
| 2024 | Dec 31, 2024 | -$15.64M | -198.8% |
| 2023 | Dec 29, 2023 | $15.84M | – |
| 2022 | Dec 30, 2022 | -$33.05M | – |
| 2021 | Dec 31, 2021 | -$11.20M | -128.9% |
| 2020 | Dec 31, 2020 | $38.76M | -87.0% |
| 2019 | Dec 31, 2019 | $298.30M | +7.1% |
| 2018 | Dec 31, 2018 | $278.64M | -12.9% |
| 2017 | Dec 29, 2017 | $319.82M | -9.3% |
| 2016 | Dec 30, 2016 | $352.63M | +621.5% |
| 2015 | Dec 31, 2015 | $48.88M | -29.8% |
| 2014 | Dec 31, 2014 | $69.61M | – |
See a number that looks wrong?